Aurobindo Takes Pole Position In Less Genericized Portuguese Market

India’s Aurobindo Pharma has catapulted to the top spot in the Portuguese generic market with the buyout of Generis Farmacêutica SA and hopes to cash in on its extensive portfolio and brand loyalty to drive growth.

Portuguese medicine

Aurobindo Pharma Ltd. has begun 2017 with an acquisition, snapping up Generis Farmacêutica SA in Portugal for €135m from Magnum Capital Partners.

The deal, valued at about two times Generis’ net sales in 2016, has been routed through Aurobindo’s wholly owned step-down...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip